loadpatents
name:-0.063009977340698
name:-0.021043062210083
name:-0.00059604644775391
Koverech; Aleardo Patent Filings

Koverech; Aleardo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koverech; Aleardo.The latest application filed is for "compounds useful for increasing neurogenesis in neural tissue".

Company Profile
0.24.41
  • Koverech; Aleardo - Rome IT
  • Koverech; Aleardo - Pomezia IT
  • Koverech; Aleardo - Roma IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds useful for increasing neurogenesis in neural tissue
Grant 11,433,043 - Grilli , et al. September 6, 2
2022-09-06
Compounds Useful For Increasing Neurogenesis In Neural Tissue
App 20200323809 - GRILLI; Mariagrazia ;   et al.
2020-10-15
Compounds Useful For Increasing Neurogenesis In Neural Tissue
App 20160310458 - GRILLI; Mariagrazia ;   et al.
2016-10-27
Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
Grant 9,457,037 - Virmani , et al. October 4, 2
2016-10-04
Composition useful for the treatment of lipid metabolism disorders
Grant 9,125,903 - Koverech , et al. September 8, 2
2015-09-08
Therapeutical method for the treatment of the Leber optic neuropathy
Grant 9,114,120 - Cavazza , et al. August 25, 2
2015-08-25
Compound Useful For Treating Cellulite
App 20140322149 - KOVERECH; Aleardo
2014-10-30
Composition For Tipical Use For Treating Skin Disorders
App 20140294921 - Koverech; Aleardo ;   et al.
2014-10-02
Compound With Antibacterial Activity
App 20140294922 - Koverech; Aleardo
2014-10-02
Composition Useful For The Treatment Of Lipid Metabolism Disorders
App 20140086985 - Koverech; Aleardo ;   et al.
2014-03-27
Compounds Useful For The Prevention Or Treatment Of Accommodative Asthenopia
App 20140079809 - PESCOSOLIDO; Nicola ;   et al.
2014-03-20
Therapeutical Method For The Treatment Of The Leber Optic Neuropathy
App 20140051757 - Cavazza; Claudio ;   et al.
2014-02-20
COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
App 20140018310 - Virmani; Mohamed Ashraf ;   et al.
2014-01-16
Compounds Useful For Increasing Neurogenesis In Neural Tissue
App 20130203848 - Grilli; Mariagrazia ;   et al.
2013-08-08
Gel Useful For The Delivery Of Ophthalmic Drugs
App 20130137651 - LONGO; Antonio ;   et al.
2013-05-30
Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
Grant 8,415,392 - Cavallini , et al. April 9, 2
2013-04-09
Use of L-carnitine for the treatment of cardiovascular diseases
Grant 8,394,854 - Koverech March 12, 2
2013-03-12
Gel useful for the delivery of ophthalmic drugs
Grant 8,389,014 - Longo , et al. March 5, 2
2013-03-05
Composition Comprising As Active Ingredient L-carnitine In Combination With A Solar Filter, For The Prevention And/or Treatment Of Pathologies Of The Eye Due To Ultraviolet Radiation
App 20130045940 - Pescosolido; Nicola ;   et al.
2013-02-21
Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
Grant 8,377,988 - Koverech , et al. February 19, 2
2013-02-19
COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
App 20130005670 - Virmani; Mohamed Ashraf ;   et al.
2013-01-03
Use of alkanoyl L-carnitine for the treatment of erectile dysfunction
Grant 8,343,979 - Koverech , et al. January 1, 2
2013-01-01
Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
Grant 8,158,679 - Koverech , et al. April 17, 2
2012-04-17
Use Of Alkanoyl L-carnitine For The Treatment Of Erectile Dysfunction
App 20120041005 - Koverech; Aleardo ;   et al.
2012-02-16
Compounds Useful For The Prevention Or Treatment Of Accomodative Asthenopia
App 20110268817 - Pescosolido; Nicola ;   et al.
2011-11-03
Compound Useful For Treating Cellulite
App 20110217252 - Koverech; Aleardo
2011-09-08
Use of acetyl L-carnitine for the treatment of fibromyalgic syndrome
Grant 8,013,016 - Koverech September 6, 2
2011-09-06
Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
Grant 8,003,652 - Koverech , et al. August 23, 2
2011-08-23
Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
App 20110189152 - Virmani; Mohamed Ashraf ;   et al.
2011-08-04
Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
Grant 7,956,091 - Koverech , et al. June 7, 2
2011-06-07
Use Of L-carnitine For The Treatment Of Cardiovascular Diesases
App 20110086917 - Koverech; Aleardo
2011-04-14
Use of L-carnitine for the treatment of cardiovascular diseases
Grant 7,879,908 - Koverech February 1, 2
2011-02-01
Carnitines for treating or preventing disorders caused by andropause
Grant 7,776,913 - Koverech , et al. August 17, 2
2010-08-17
Use Of L-carnitine Or Of Alkanoyl L-carnitines For The Preparation Of A Physiological Supplement Or Medicament For Ophthalmic Use In The Form Of Eye Drops
App 20100093858 - Koverech; Aleardo ;   et al.
2010-04-15
Use Of L-carnitine For The Preparation Of A Medicament In The Form Of Eye-drops For Treating Corneal Diseases
App 20100068300 - Koverech; Aleardo ;   et al.
2010-03-18
Gel Useful For The Delivery Of Ophthalmic Drugs
App 20100069482 - Longo; Antonio ;   et al.
2010-03-18
Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for opthalmic use in the form of eye drops
Grant 7,655,698 - Koverech , et al. February 2, 2
2010-02-02
Use Of Acetyl L-carnitine For The Treatment Of Fibromyalgic Syndrome
App 20090076146 - Koverech; Aleardo
2009-03-19
Use of L-carnitine for the treatment of cardiovascular diseases
App 20090042983 - Koverech; Aleardo
2009-02-12
Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
App 20090012169 - Cavallini; Giorgio ;   et al.
2009-01-08
Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
App 20080287539 - Koverech; Aleardo ;   et al.
2008-11-20
Use of Acetyl L-Carnitine In Combination With Propionyl L-Carnitine and Sildenafil for the Treatment of Erectile Dysfunction
App 20080090906 - Koverech; Aleardo ;   et al.
2008-04-17
Use Of L-carnitine Or Of Alkanoyl L-carnitines For The Preparation Of A Physiological Supplement Or Medicament For Ophthalmic Use In The Form Of Eye Drops
App 20070265338 - Koverech; Aleardo ;   et al.
2007-11-15
Use Of L-Carnitine For The Treatment Of Cardiovascular Diseases
App 20070207970 - Koverech; Aleardo
2007-09-06
Use of an alkanoyl L-carnitine for the treatment of the erectile dysfunction
App 20070117762 - Koverech; Aleardo ;   et al.
2007-05-24
Administration of isovaleryl L-carnitine to stimulate osteoblastic activity
Grant 7,084,174 - Zallone , et al. August 1, 2
2006-08-01
Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
App 20060135606 - Koverech; Aleardo ;   et al.
2006-06-22
Use of l-carnitine for the treatment of cardiovascular diseases
App 20060052450 - Koverech; Aleardo
2006-03-09
Use of isovaleryl L-carnitine for the preparation of a medicament for the prevention and cure of fractures
App 20050143458 - Zallone, Alberta ;   et al.
2005-06-30
Use of isovaleryl L-carnitine to increase healing of bone fractures
Grant 6,906,102 - Koverech , et al. June 14, 2
2005-06-14
Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
App 20050107470 - Cavillini, Giorgio ;   et al.
2005-05-19
Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
App 20050080018 - Koverech, Aleardo ;   et al.
2005-04-14
Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
App 20050038044 - Koverech, Aleardo ;   et al.
2005-02-17
Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
App 20040077718 - Koverech, Aleardo ;   et al.
2004-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed